Matrix metalloproteinases and their clinical relevance in urinary bladder cancer

Bladder Cancer Risk Associated with Genotypic Polymorphism of the Matrix Metalloproteinase-1 and 7 in North Indian Population

(2013) Priyanka Srivastava et al.   DISEASE MARKERS

Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival

(2010) Birgitte V. Offersen et al.   ACTA ONCOLOGICA

Role of MMP-3 and MMP-9 and Their Haplotypes in Risk of Bladder Cancer in North Indian Cohort

(2010) Priyanka Srivastava et al.   ANNALS OF SURGICAL ONCOLOGY

Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma

(2010) A.K. Kivisaari et al.   BRITISH JOURNAL OF DERMATOLOGY

A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer

(2010) Robert S. Svatek et al.   CANCER

p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity

(2010) B. Kumar et al.   CANCER RESEARCH

Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer

(2010) Tibor Szarvas et al.   CANCER SCIENCE

Matrix Metalloproteinase Inhibitors

(2010) György Dormán et al.   DRUGS

Regulation of matrix metalloproteinase activity in health and disease

(2010) Elin Hadler-Olsen et al.   FEBS Journal

Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy

(2010) Tibor Szarvas et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular screening for bladder cancer: progress and potential

(2010) Anirban P. Mitra et al.   Nature Reviews Urology

Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models

(2009) Miriam Fanjul-Fernández et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The Effect of TGF-β2on MMP-2 Production and Activity in Highly Metastatic Human Bladder Carcinoma Cell Line 5637

(2009) Ehsan Dehnavi et al.   CANCER INVESTIGATION

The suppressive effect of Rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells

(2009) Horng-Rong Chang et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer

(2009) Roopali Roy et al.   JOURNAL OF CLINICAL ONCOLOGY

A Novel Approach to Using Matrix Metalloproteinases for Bladder Cancer

(2009) Cecilia A. Fernández et al.   JOURNAL OF UROLOGY

The bladder extracellular matrix. Part I: architecture, development and disease

(2009) Karen J. Aitken et al.   Nature Reviews Urology

Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas

(2009) Gamze Donmez et al.   PATHOLOGY RESEARCH AND PRACTICE

The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin

(2009) Vanessa Almendro et al.   PLoS One

MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3

(2008) K Saeb-Parsy et al.   BRITISH JOURNAL OF CANCER

Imaging matrix metalloproteinases in cancer

(2008) Randy L. Scherer et al.   CANCER AND METASTASIS REVIEWS

HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion

(2008) Rose Du et al.   CANCER CELL

Oct-3/4 Expression Reflects Tumor Progression and Regulates Motility of Bladder Cancer Cells

(2008) C.-C. Chang et al.   CANCER RESEARCH

Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells

(2008) K. D. Cowden Dahl et al.   CANCER RESEARCH

Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer

(2008) Hui Liu et al.   CANCER SCIENCE

Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas

(2008) Azizbek Ramankulov et al.   CANCER SCIENCE

Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy

(2008) E. R. Smith et al.   CLINICAL CANCER RESEARCH

Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species

(2008) R. Roy et al.   CLINICAL CANCER RESEARCH

Impact of Blood Sampling on the Circulating Matrix Metalloproteinases 1, 2, 3, 7, 8, and 9

(2008) K. Jung et al.   CLINICAL CHEMISTRY

The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis

(2008) William Cruz-Munoz et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Signaling pathway for TNF-α-induced MMP-9 expression: Mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells

(2008) Se-Jung Lee et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Low Circulating Levels of ProMMP-2 Are Associated with Adverse Prognosis in Bladder Cancer

(2008) Kaija Vasala et al.   TUMOR BIOLOGY

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

(2007) Shahrokh F. Shariat et al.   CANCER